0000051143 false Capital stock, par value $.20 per share IBM CHX 0000051143 2022-09-13 2022-09-13 0000051143 us-gaap:CommonStockMember exch:XCHI 2022-09-13 2022-09-13 0000051143 us-gaap:CommonStockMember exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.25PercentDue2023Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.375PercentDue2023Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.125PercentDue2024Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes2.875PercentDue2025Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes0.875PercentDue2030Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.250PercentDue2034Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2022-09-13 2022-09-13 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2022-09-13 2022-09-13 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2022-09-13 2022-09-13 0000051143 ibm:Debentures7.00PercentDue2025Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Debentures5.875PercentDue2032Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2022-09-13 2022-09-13 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2022-09-13 2022-09-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares


Title of each class
Trading symbol





WASHINGTON, D.C. 20549  











Date of Report: September 13, 2022

(Date of earliest event reported)





(Exact name of registrant as specified in its charter)




New York   001-2360   13-0871985
(State or other jurisdiction   (Commission   (IRS employee
of incorporation)   File No.)   Indemnification No.)


One New Orchard Road

Armonk, New York   10504
(Address of principal executive offices)   (Zip Code)



(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Title of each class   Trading Symbol(s)   Name of each exchange
on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
        NYSE Chicago
1.250% Notes due 2023   IBM 23A   New York Stock Exchange
0.375% Notes due 2023   IBM 23B   New York Stock Exchange
1.125% Notes due 2024   IBM 24A   New York Stock Exchange
2.875% Notes due 2025   IBM 25A   New York Stock Exchange
0.950% Notes due 2025   IBM 25B   New York Stock Exchange
0.875% Notes due 2025   IBM 25C   New York Stock Exchange
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
0.875% Notes due 2030   IBM 30   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
1.250% Notes due 2034   IBM 34   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
7.00% Debentures due 2025   IBM 25   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
5.875% Debentures due 2032   IBM 32D   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange


Indicate by check mark whether the registrar is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230 405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§12b-2 of this chapter).


Emerging growth company ¨


If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨








Item 8.01.  Other Events.  


On September 7, 2022, International Business Machines Corporation (“IBM” or the “Company”) and State Street Global Advisors Trust Company, as independent fiduciary of the IBM Personal Pension Plan (the “Plan”), entered into two separate commitment agreements, one with The Prudential Insurance Company of America (“Prudential”) and one with Metropolitan Life Insurance Company (collectively, the “Insurers”) under which the Plan agreed to purchase nonparticipating single premium group annuity contracts that will transfer to the Insurers approximately $16 billion of the Plan’s defined benefit pension obligations related to certain pension benefits that began to be paid prior to 2016.


The purchase of the group annuity contracts closed on September 13, 2022. The contracts cover approximately 100,000 IBM participants and beneficiaries (the “Transferred Participants”). Under the group annuity contracts, each Insurer has made an irrevocable commitment, and will be solely responsible, to pay 50% of the pension benefits of each Transferred Participant that are due on and after January 1, 2023. Prudential will be the lead administrator. The transaction will result in no changes to the amount of benefits payable to the Transferred Participants.


The purchase of the group annuity contracts was funded directly by assets of the Plan and required no cash or asset contributions of the Company. As a result of the transaction, the Company expects to recognize a one-time non-cash pre-tax pension settlement charge of approximately $5.9 billion ($4.4 billion net of tax) in the third quarter of 2022. The actual charge will depend on finalization of the actuarial and other assumptions. The pre-tax charge was not included in the GAAP forward-looking information released on July 18, 2022. This charge will not impact the Company’s third quarter or full year 2022 operating (non-GAAP) profit or free cash flow.


Forward-Looking Statements


Certain statements contained in this Form 8-K may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“Reform Act”). Forward-looking statements are based on the company’s current assumptions regarding future business and financial performance. These statements by their nature address matters that are uncertain to different degrees. The company may also make forward-looking statements in other reports filed with the Securities and Exchange Commission (SEC), in materials delivered to stockholders and in press releases. In addition, the company’s representatives may from time to time make oral forward-looking statements. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Words such as “anticipates,” “believes,” “expects,” “estimates,” “intends,” “plans,” “projects,” and similar expressions, may identify such forward-looking statements. Any forward-looking statement in this Form 8-K speaks only as of the date on which it is made. Except as required by law, the company assumes no obligation to update or revise any forward-looking statements.


Item 9.01.  Financial Statements and Exhibits.


(d) Exhibits


Exhibit No.   Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


Date: September 13, 2022


  By: /s/Frank Sedlarcik
    Frank Sedlarcik
    Vice President, Assistant General Counsel and Secretary